These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
698 related articles for article (PubMed ID: 23060265)
21. Induction vemurafenib followed by consolidative radiation therapy for surgically incurable melanoma. Seeley AR; De Los Santos JF; Conry RM Melanoma Res; 2015 Jun; 25(3):246-51. PubMed ID: 25746037 [TBL] [Abstract][Full Text] [Related]
22. BRAF mutation testing algorithm for vemurafenib treatment in melanoma: recommendations from an expert panel. Gonzalez D; Fearfield L; Nathan P; Tanière P; Wallace A; Brown E; Harwood C; Marsden J; Whittaker S Br J Dermatol; 2013 Apr; 168(4):700-7. PubMed ID: 23360189 [TBL] [Abstract][Full Text] [Related]
23. Treatment of BRAF-mutant melanoma: the role of vemurafenib and other therapies. Jang S; Atkins MB Clin Pharmacol Ther; 2014 Jan; 95(1):24-31. PubMed ID: 24080641 [TBL] [Abstract][Full Text] [Related]
24. Vemurafenib therapy for stage IV melanoma with V600G-mutation. Lang N; Weisser A; Enk A; Hassel JC J Dtsch Dermatol Ges; 2013 Dec; 11(12):1198-9. PubMed ID: 24016000 [No Abstract] [Full Text] [Related]
25. Advances in the management of melanoma: targeted therapy, immunotherapy and future directions. Dean E; Lorigan P Expert Rev Anticancer Ther; 2012 Nov; 12(11):1437-48. PubMed ID: 23249108 [TBL] [Abstract][Full Text] [Related]